BillionToOne, акция обыкновенная (US0901681058, BLLN, BLLN.P)

BillionToOne Inc is a United States-based precision diagnostics company. The Company provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.